Xenon Pharmaceuticals holds 2025 Annual Meeting; all director nominees elected

Xenon Pharmaceuticals Inc.

All 8 director nominees elected with over 64M votes each; broker non-votes of 2.2M.
Advisory say-on-pay passed with 67.3M for, 2.1M against, 0.5M abstain.
Appointment of PricewaterhouseCoopers LLP as auditor approved (72.0M for, 34K withheld).
Auditor remuneration authority approved (72.0M for, 25K against, 11K abstain).
Approximately 94.1% of outstanding common shares voted at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.